OTC Markets Group, operator of regulated markets for more than 12,000 U.S. and international securities, today announced the appointment of JP Chan as Senior Vice President and Regional Head, Asia-Pacific.

Chan will lead OTC Markets’ regional team out of Hong Kong, overseeing Asia-Pacific, and working with issuers, market participants and investors to efficiently access US capital markets via OTC Markets Group.

“The world’s investors want access to Asia-Pacific companies, and Asia-Pacific companies want access to U.S. capital. OTC Markets is the infrastructure that connects them. Establishing a permanent presence in Hong Kong, with a team led by JP Chan, is how we make that connection work at the scale this market demands,” said Cromwell Coulson, President and CEO of OTC Markets Group.

Chan has spent more than two decades in Hong Kong building institutional relationships with the CFOs, IROs, and capital markets professionals who are OTC Markets’ core target audience across Asia-Pacific. He most recently served as Sales Director at Visible Alpha covering Greater China and ASEAN, and previously held senior roles at IHS Markit, S&P Capital IQ, Dealogic, and Thomson Reuters.

At OTC Markets, he will lead a regional team responsible for issuer development, partner engagement, and data distribution as demand for cross-border market intelligence continues to grow.

“There has never been a more direct path for companies in this region to reach U.S. investors. OTC Markets is that path. My job is to open the door for issuers to connect into the U.S. market and assist APAC investors in accessing global names via our 24×5 markets,” said JP Chan.

The Hong Kong office also anchors OTC Markets’ overnight trading strategy in the region. The investor landscape is shifting and the numbers reflect it: MOON ATS® dollar volume was nearly 6 times higher in Q1 2026 compared to Q4 2025.